Natdac contains the active ingredient Daclatasvir. Daclatasvir is used with other antiviral medicines in the treatment chronic hepatitis C infection of genotype 1 or genotype 3 in adults. Natdac must be taken in combination with sofosbuvir, or with sofosbuvir and ribavirin. It must not be taken by itself.